Trastuzumab Emtansine for Injection Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Trastuzumab Emtansine for Injection in global, including the following market information:
Global Trastuzumab Emtansine for Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Trastuzumab Emtansine for Injection Market Sales, 2017-2022, 2023-2028, (K L)
Global top five Trastuzumab Emtansine for Injection companies in 2021 (%)
The global Trastuzumab Emtansine for Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
60mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Trastuzumab Emtansine for Injection include Genentech, Daiichi Sankyo, Amgen, Pfizer, Samsung Bioepis, Mylan(Viatris), Celltrion, Roche and Accord Healthcare, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Trastuzumab Emtansine for Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Trastuzumab Emtansine for Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K L)
Global Trastuzumab Emtansine for Injection Market Segment Percentages, by Type, 2021 (%)
Global Trastuzumab Emtansine for Injection Market Segment Percentages, by Application, 2021 (%)
Global Trastuzumab Emtansine for Injection Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Trastuzumab Emtansine for Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Trastuzumab Emtansine for Injection revenues share in global market, 2021 (%)
Key companies Trastuzumab Emtansine for Injection sales in global market, 2017-2022 (Estimated), (K L)
Key companies Trastuzumab Emtansine for Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Trastuzumab Emtansine for Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Trastuzumab Emtansine for Injection Market Sales, 2017-2022, 2023-2028, (K L)
Global top five Trastuzumab Emtansine for Injection companies in 2021 (%)
The global Trastuzumab Emtansine for Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
60mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Trastuzumab Emtansine for Injection include Genentech, Daiichi Sankyo, Amgen, Pfizer, Samsung Bioepis, Mylan(Viatris), Celltrion, Roche and Accord Healthcare, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Trastuzumab Emtansine for Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Trastuzumab Emtansine for Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K L)
Global Trastuzumab Emtansine for Injection Market Segment Percentages, by Type, 2021 (%)
- 60mg
- 100mg
- 150mg
- 160mg
- Others
Global Trastuzumab Emtansine for Injection Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinics
- Others
Global Trastuzumab Emtansine for Injection Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Trastuzumab Emtansine for Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Trastuzumab Emtansine for Injection revenues share in global market, 2021 (%)
Key companies Trastuzumab Emtansine for Injection sales in global market, 2017-2022 (Estimated), (K L)
Key companies Trastuzumab Emtansine for Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Genentech
- Daiichi Sankyo
- Amgen
- Pfizer
- Samsung Bioepis
- Mylan(Viatris)
- Celltrion
- Roche
- Accord Healthcare
- Nippon Kayaku
- Chugai Pharmaceutical
- Henlius
- Orifarm
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Trastuzumab Emtansine for Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Trastuzumab Emtansine for Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL TRASTUZUMAB EMTANSINE FOR INJECTION OVERALL MARKET SIZE
2.1 Global Trastuzumab Emtansine for Injection Market Size: 2021 VS 2028
2.2 Global Trastuzumab Emtansine for Injection Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Trastuzumab Emtansine for Injection Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Trastuzumab Emtansine for Injection Players in Global Market
3.2 Top Global Trastuzumab Emtansine for Injection Companies Ranked by Revenue
3.3 Global Trastuzumab Emtansine for Injection Revenue by Companies
3.4 Global Trastuzumab Emtansine for Injection Sales by Companies
3.5 Global Trastuzumab Emtansine for Injection Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Trastuzumab Emtansine for Injection Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Trastuzumab Emtansine for Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Trastuzumab Emtansine for Injection Players in Global Market
3.8.1 List of Global Tier 1 Trastuzumab Emtansine for Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Trastuzumab Emtansine for Injection Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Trastuzumab Emtansine for Injection Market Size Markets, 2021 & 2028
4.1.2 60mg
4.1.3 100mg
4.1.4 150mg
4.1.5 160mg
4.1.6 Others
4.2 By Type - Global Trastuzumab Emtansine for Injection Revenue & Forecasts
4.2.1 By Type - Global Trastuzumab Emtansine for Injection Revenue, 2017-2022
4.2.2 By Type - Global Trastuzumab Emtansine for Injection Revenue, 2023-2028
4.2.3 By Type - Global Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
4.3 By Type - Global Trastuzumab Emtansine for Injection Sales & Forecasts
4.3.1 By Type - Global Trastuzumab Emtansine for Injection Sales, 2017-2022
4.3.2 By Type - Global Trastuzumab Emtansine for Injection Sales, 2023-2028
4.3.3 By Type - Global Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
4.4 By Type - Global Trastuzumab Emtansine for Injection Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Trastuzumab Emtansine for Injection Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Trastuzumab Emtansine for Injection Revenue & Forecasts
5.2.1 By Application - Global Trastuzumab Emtansine for Injection Revenue, 2017-2022
5.2.2 By Application - Global Trastuzumab Emtansine for Injection Revenue, 2023-2028
5.2.3 By Application - Global Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
5.3 By Application - Global Trastuzumab Emtansine for Injection Sales & Forecasts
5.3.1 By Application - Global Trastuzumab Emtansine for Injection Sales, 2017-2022
5.3.2 By Application - Global Trastuzumab Emtansine for Injection Sales, 2023-2028
5.3.3 By Application - Global Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
5.4 By Application - Global Trastuzumab Emtansine for Injection Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Trastuzumab Emtansine for Injection Market Size, 2021 & 2028
6.2 By Region - Global Trastuzumab Emtansine for Injection Revenue & Forecasts
6.2.1 By Region - Global Trastuzumab Emtansine for Injection Revenue, 2017-2022
6.2.2 By Region - Global Trastuzumab Emtansine for Injection Revenue, 2023-2028
6.2.3 By Region - Global Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
6.3 By Region - Global Trastuzumab Emtansine for Injection Sales & Forecasts
6.3.1 By Region - Global Trastuzumab Emtansine for Injection Sales, 2017-2022
6.3.2 By Region - Global Trastuzumab Emtansine for Injection Sales, 2023-2028
6.3.3 By Region - Global Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Trastuzumab Emtansine for Injection Revenue, 2017-2028
6.4.2 By Country - North America Trastuzumab Emtansine for Injection Sales, 2017-2028
6.4.3 US Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.4.4 Canada Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.4.5 Mexico Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Trastuzumab Emtansine for Injection Revenue, 2017-2028
6.5.2 By Country - Europe Trastuzumab Emtansine for Injection Sales, 2017-2028
6.5.3 Germany Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.5.4 France Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.5.5 U.K. Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.5.6 Italy Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.5.7 Russia Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.5.8 Nordic Countries Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.5.9 Benelux Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Trastuzumab Emtansine for Injection Revenue, 2017-2028
6.6.2 By Region - Asia Trastuzumab Emtansine for Injection Sales, 2017-2028
6.6.3 China Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.6.4 Japan Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.6.5 South Korea Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.6.6 Southeast Asia Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.6.7 India Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Trastuzumab Emtansine for Injection Revenue, 2017-2028
6.7.2 By Country - South America Trastuzumab Emtansine for Injection Sales, 2017-2028
6.7.3 Brazil Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.7.4 Argentina Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Trastuzumab Emtansine for Injection Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Trastuzumab Emtansine for Injection Sales, 2017-2028
6.8.3 Turkey Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.8.4 Israel Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.8.5 Saudi Arabia Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.8.6 UAE Trastuzumab Emtansine for Injection Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Genentech
7.1.1 Genentech Corporate Summary
7.1.2 Genentech Business Overview
7.1.3 Genentech Trastuzumab Emtansine for Injection Major Product Offerings
7.1.4 Genentech Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.1.5 Genentech Key News
7.2 Daiichi Sankyo
7.2.1 Daiichi Sankyo Corporate Summary
7.2.2 Daiichi Sankyo Business Overview
7.2.3 Daiichi Sankyo Trastuzumab Emtansine for Injection Major Product Offerings
7.2.4 Daiichi Sankyo Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.2.5 Daiichi Sankyo Key News
7.3 Amgen
7.3.1 Amgen Corporate Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen Trastuzumab Emtansine for Injection Major Product Offerings
7.3.4 Amgen Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.3.5 Amgen Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Trastuzumab Emtansine for Injection Major Product Offerings
7.4.4 Pfizer Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.4.5 Pfizer Key News
7.5 Samsung Bioepis
7.5.1 Samsung Bioepis Corporate Summary
7.5.2 Samsung Bioepis Business Overview
7.5.3 Samsung Bioepis Trastuzumab Emtansine for Injection Major Product Offerings
7.5.4 Samsung Bioepis Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.5.5 Samsung Bioepis Key News
7.6 Mylan(Viatris)
7.6.1 Mylan(Viatris) Corporate Summary
7.6.2 Mylan(Viatris) Business Overview
7.6.3 Mylan(Viatris) Trastuzumab Emtansine for Injection Major Product Offerings
7.6.4 Mylan(Viatris) Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.6.5 Mylan(Viatris) Key News
7.7 Celltrion
7.7.1 Celltrion Corporate Summary
7.7.2 Celltrion Business Overview
7.7.3 Celltrion Trastuzumab Emtansine for Injection Major Product Offerings
7.7.4 Celltrion Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.7.5 Celltrion Key News
7.8 Roche
7.8.1 Roche Corporate Summary
7.8.2 Roche Business Overview
7.8.3 Roche Trastuzumab Emtansine for Injection Major Product Offerings
7.8.4 Roche Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.8.5 Roche Key News
7.9 Accord Healthcare
7.9.1 Accord Healthcare Corporate Summary
7.9.2 Accord Healthcare Business Overview
7.9.3 Accord Healthcare Trastuzumab Emtansine for Injection Major Product Offerings
7.9.4 Accord Healthcare Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.9.5 Accord Healthcare Key News
7.10 Nippon Kayaku
7.10.1 Nippon Kayaku Corporate Summary
7.10.2 Nippon Kayaku Business Overview
7.10.3 Nippon Kayaku Trastuzumab Emtansine for Injection Major Product Offerings
7.10.4 Nippon Kayaku Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.10.5 Nippon Kayaku Key News
7.11 Chugai Pharmaceutical
7.11.1 Chugai Pharmaceutical Corporate Summary
7.11.2 Chugai Pharmaceutical Trastuzumab Emtansine for Injection Business Overview
7.11.3 Chugai Pharmaceutical Trastuzumab Emtansine for Injection Major Product Offerings
7.11.4 Chugai Pharmaceutical Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.11.5 Chugai Pharmaceutical Key News
7.12 Henlius
7.12.1 Henlius Corporate Summary
7.12.2 Henlius Trastuzumab Emtansine for Injection Business Overview
7.12.3 Henlius Trastuzumab Emtansine for Injection Major Product Offerings
7.12.4 Henlius Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.12.5 Henlius Key News
7.13 Orifarm
7.13.1 Orifarm Corporate Summary
7.13.2 Orifarm Trastuzumab Emtansine for Injection Business Overview
7.13.3 Orifarm Trastuzumab Emtansine for Injection Major Product Offerings
7.13.4 Orifarm Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.13.5 Orifarm Key News
8 GLOBAL TRASTUZUMAB EMTANSINE FOR INJECTION PRODUCTION CAPACITY, ANALYSIS
8.1 Global Trastuzumab Emtansine for Injection Production Capacity, 2017-2028
8.2 Trastuzumab Emtansine for Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Trastuzumab Emtansine for Injection Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 TRASTUZUMAB EMTANSINE FOR INJECTION SUPPLY CHAIN ANALYSIS
10.1 Trastuzumab Emtansine for Injection Industry Value Chain
10.2 Trastuzumab Emtansine for Injection Upstream Market
10.3 Trastuzumab Emtansine for Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Trastuzumab Emtansine for Injection Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Trastuzumab Emtansine for Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Trastuzumab Emtansine for Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL TRASTUZUMAB EMTANSINE FOR INJECTION OVERALL MARKET SIZE
2.1 Global Trastuzumab Emtansine for Injection Market Size: 2021 VS 2028
2.2 Global Trastuzumab Emtansine for Injection Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Trastuzumab Emtansine for Injection Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Trastuzumab Emtansine for Injection Players in Global Market
3.2 Top Global Trastuzumab Emtansine for Injection Companies Ranked by Revenue
3.3 Global Trastuzumab Emtansine for Injection Revenue by Companies
3.4 Global Trastuzumab Emtansine for Injection Sales by Companies
3.5 Global Trastuzumab Emtansine for Injection Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Trastuzumab Emtansine for Injection Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Trastuzumab Emtansine for Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Trastuzumab Emtansine for Injection Players in Global Market
3.8.1 List of Global Tier 1 Trastuzumab Emtansine for Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Trastuzumab Emtansine for Injection Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Trastuzumab Emtansine for Injection Market Size Markets, 2021 & 2028
4.1.2 60mg
4.1.3 100mg
4.1.4 150mg
4.1.5 160mg
4.1.6 Others
4.2 By Type - Global Trastuzumab Emtansine for Injection Revenue & Forecasts
4.2.1 By Type - Global Trastuzumab Emtansine for Injection Revenue, 2017-2022
4.2.2 By Type - Global Trastuzumab Emtansine for Injection Revenue, 2023-2028
4.2.3 By Type - Global Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
4.3 By Type - Global Trastuzumab Emtansine for Injection Sales & Forecasts
4.3.1 By Type - Global Trastuzumab Emtansine for Injection Sales, 2017-2022
4.3.2 By Type - Global Trastuzumab Emtansine for Injection Sales, 2023-2028
4.3.3 By Type - Global Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
4.4 By Type - Global Trastuzumab Emtansine for Injection Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Trastuzumab Emtansine for Injection Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Trastuzumab Emtansine for Injection Revenue & Forecasts
5.2.1 By Application - Global Trastuzumab Emtansine for Injection Revenue, 2017-2022
5.2.2 By Application - Global Trastuzumab Emtansine for Injection Revenue, 2023-2028
5.2.3 By Application - Global Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
5.3 By Application - Global Trastuzumab Emtansine for Injection Sales & Forecasts
5.3.1 By Application - Global Trastuzumab Emtansine for Injection Sales, 2017-2022
5.3.2 By Application - Global Trastuzumab Emtansine for Injection Sales, 2023-2028
5.3.3 By Application - Global Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
5.4 By Application - Global Trastuzumab Emtansine for Injection Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Trastuzumab Emtansine for Injection Market Size, 2021 & 2028
6.2 By Region - Global Trastuzumab Emtansine for Injection Revenue & Forecasts
6.2.1 By Region - Global Trastuzumab Emtansine for Injection Revenue, 2017-2022
6.2.2 By Region - Global Trastuzumab Emtansine for Injection Revenue, 2023-2028
6.2.3 By Region - Global Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
6.3 By Region - Global Trastuzumab Emtansine for Injection Sales & Forecasts
6.3.1 By Region - Global Trastuzumab Emtansine for Injection Sales, 2017-2022
6.3.2 By Region - Global Trastuzumab Emtansine for Injection Sales, 2023-2028
6.3.3 By Region - Global Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Trastuzumab Emtansine for Injection Revenue, 2017-2028
6.4.2 By Country - North America Trastuzumab Emtansine for Injection Sales, 2017-2028
6.4.3 US Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.4.4 Canada Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.4.5 Mexico Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Trastuzumab Emtansine for Injection Revenue, 2017-2028
6.5.2 By Country - Europe Trastuzumab Emtansine for Injection Sales, 2017-2028
6.5.3 Germany Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.5.4 France Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.5.5 U.K. Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.5.6 Italy Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.5.7 Russia Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.5.8 Nordic Countries Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.5.9 Benelux Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Trastuzumab Emtansine for Injection Revenue, 2017-2028
6.6.2 By Region - Asia Trastuzumab Emtansine for Injection Sales, 2017-2028
6.6.3 China Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.6.4 Japan Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.6.5 South Korea Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.6.6 Southeast Asia Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.6.7 India Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Trastuzumab Emtansine for Injection Revenue, 2017-2028
6.7.2 By Country - South America Trastuzumab Emtansine for Injection Sales, 2017-2028
6.7.3 Brazil Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.7.4 Argentina Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Trastuzumab Emtansine for Injection Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Trastuzumab Emtansine for Injection Sales, 2017-2028
6.8.3 Turkey Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.8.4 Israel Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.8.5 Saudi Arabia Trastuzumab Emtansine for Injection Market Size, 2017-2028
6.8.6 UAE Trastuzumab Emtansine for Injection Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Genentech
7.1.1 Genentech Corporate Summary
7.1.2 Genentech Business Overview
7.1.3 Genentech Trastuzumab Emtansine for Injection Major Product Offerings
7.1.4 Genentech Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.1.5 Genentech Key News
7.2 Daiichi Sankyo
7.2.1 Daiichi Sankyo Corporate Summary
7.2.2 Daiichi Sankyo Business Overview
7.2.3 Daiichi Sankyo Trastuzumab Emtansine for Injection Major Product Offerings
7.2.4 Daiichi Sankyo Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.2.5 Daiichi Sankyo Key News
7.3 Amgen
7.3.1 Amgen Corporate Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen Trastuzumab Emtansine for Injection Major Product Offerings
7.3.4 Amgen Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.3.5 Amgen Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Trastuzumab Emtansine for Injection Major Product Offerings
7.4.4 Pfizer Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.4.5 Pfizer Key News
7.5 Samsung Bioepis
7.5.1 Samsung Bioepis Corporate Summary
7.5.2 Samsung Bioepis Business Overview
7.5.3 Samsung Bioepis Trastuzumab Emtansine for Injection Major Product Offerings
7.5.4 Samsung Bioepis Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.5.5 Samsung Bioepis Key News
7.6 Mylan(Viatris)
7.6.1 Mylan(Viatris) Corporate Summary
7.6.2 Mylan(Viatris) Business Overview
7.6.3 Mylan(Viatris) Trastuzumab Emtansine for Injection Major Product Offerings
7.6.4 Mylan(Viatris) Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.6.5 Mylan(Viatris) Key News
7.7 Celltrion
7.7.1 Celltrion Corporate Summary
7.7.2 Celltrion Business Overview
7.7.3 Celltrion Trastuzumab Emtansine for Injection Major Product Offerings
7.7.4 Celltrion Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.7.5 Celltrion Key News
7.8 Roche
7.8.1 Roche Corporate Summary
7.8.2 Roche Business Overview
7.8.3 Roche Trastuzumab Emtansine for Injection Major Product Offerings
7.8.4 Roche Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.8.5 Roche Key News
7.9 Accord Healthcare
7.9.1 Accord Healthcare Corporate Summary
7.9.2 Accord Healthcare Business Overview
7.9.3 Accord Healthcare Trastuzumab Emtansine for Injection Major Product Offerings
7.9.4 Accord Healthcare Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.9.5 Accord Healthcare Key News
7.10 Nippon Kayaku
7.10.1 Nippon Kayaku Corporate Summary
7.10.2 Nippon Kayaku Business Overview
7.10.3 Nippon Kayaku Trastuzumab Emtansine for Injection Major Product Offerings
7.10.4 Nippon Kayaku Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.10.5 Nippon Kayaku Key News
7.11 Chugai Pharmaceutical
7.11.1 Chugai Pharmaceutical Corporate Summary
7.11.2 Chugai Pharmaceutical Trastuzumab Emtansine for Injection Business Overview
7.11.3 Chugai Pharmaceutical Trastuzumab Emtansine for Injection Major Product Offerings
7.11.4 Chugai Pharmaceutical Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.11.5 Chugai Pharmaceutical Key News
7.12 Henlius
7.12.1 Henlius Corporate Summary
7.12.2 Henlius Trastuzumab Emtansine for Injection Business Overview
7.12.3 Henlius Trastuzumab Emtansine for Injection Major Product Offerings
7.12.4 Henlius Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.12.5 Henlius Key News
7.13 Orifarm
7.13.1 Orifarm Corporate Summary
7.13.2 Orifarm Trastuzumab Emtansine for Injection Business Overview
7.13.3 Orifarm Trastuzumab Emtansine for Injection Major Product Offerings
7.13.4 Orifarm Trastuzumab Emtansine for Injection Sales and Revenue in Global (2017-2022)
7.13.5 Orifarm Key News
8 GLOBAL TRASTUZUMAB EMTANSINE FOR INJECTION PRODUCTION CAPACITY, ANALYSIS
8.1 Global Trastuzumab Emtansine for Injection Production Capacity, 2017-2028
8.2 Trastuzumab Emtansine for Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Trastuzumab Emtansine for Injection Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 TRASTUZUMAB EMTANSINE FOR INJECTION SUPPLY CHAIN ANALYSIS
10.1 Trastuzumab Emtansine for Injection Industry Value Chain
10.2 Trastuzumab Emtansine for Injection Upstream Market
10.3 Trastuzumab Emtansine for Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Trastuzumab Emtansine for Injection Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Trastuzumab Emtansine for Injection in Global Market
Table 2. Top Trastuzumab Emtansine for Injection Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Trastuzumab Emtansine for Injection Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Trastuzumab Emtansine for Injection Revenue Share by Companies, 2017-2022
Table 5. Global Trastuzumab Emtansine for Injection Sales by Companies, (K L), 2017-2022
Table 6. Global Trastuzumab Emtansine for Injection Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Trastuzumab Emtansine for Injection Price (2017-2022) & (US$/L)
Table 8. Global Manufacturers Trastuzumab Emtansine for Injection Product Type
Table 9. List of Global Tier 1 Trastuzumab Emtansine for Injection Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Trastuzumab Emtansine for Injection Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Trastuzumab Emtansine for Injection Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Trastuzumab Emtansine for Injection Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Trastuzumab Emtansine for Injection Sales (K L), 2017-2022
Table 15. By Type - Global Trastuzumab Emtansine for Injection Sales (K L), 2023-2028
Table 16. By Application – Global Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Trastuzumab Emtansine for Injection Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Trastuzumab Emtansine for Injection Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Trastuzumab Emtansine for Injection Sales (K L), 2017-2022
Table 20. By Application - Global Trastuzumab Emtansine for Injection Sales (K L), 2023-2028
Table 21. By Region – Global Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Trastuzumab Emtansine for Injection Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Trastuzumab Emtansine for Injection Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Trastuzumab Emtansine for Injection Sales (K L), 2017-2022
Table 25. By Region - Global Trastuzumab Emtansine for Injection Sales (K L), 2023-2028
Table 26. By Country - North America Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Trastuzumab Emtansine for Injection Sales, (K L), 2017-2022
Table 29. By Country - North America Trastuzumab Emtansine for Injection Sales, (K L), 2023-2028
Table 30. By Country - Europe Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Trastuzumab Emtansine for Injection Sales, (K L), 2017-2022
Table 33. By Country - Europe Trastuzumab Emtansine for Injection Sales, (K L), 2023-2028
Table 34. By Region - Asia Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Trastuzumab Emtansine for Injection Sales, (K L), 2017-2022
Table 37. By Region - Asia Trastuzumab Emtansine for Injection Sales, (K L), 2023-2028
Table 38. By Country - South America Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Trastuzumab Emtansine for Injection Sales, (K L), 2017-2022
Table 41. By Country - South America Trastuzumab Emtansine for Injection Sales, (K L), 2023-2028
Table 42. By Country - Middle East & Africa Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Trastuzumab Emtansine for Injection Sales, (K L), 2017-2022
Table 45. By Country - Middle East & Africa Trastuzumab Emtansine for Injection Sales, (K L), 2023-2028
Table 46. Genentech Corporate Summary
Table 47. Genentech Trastuzumab Emtansine for Injection Product Offerings
Table 48. Genentech Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 49. Daiichi Sankyo Corporate Summary
Table 50. Daiichi Sankyo Trastuzumab Emtansine for Injection Product Offerings
Table 51. Daiichi Sankyo Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 52. Amgen Corporate Summary
Table 53. Amgen Trastuzumab Emtansine for Injection Product Offerings
Table 54. Amgen Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 55. Pfizer Corporate Summary
Table 56. Pfizer Trastuzumab Emtansine for Injection Product Offerings
Table 57. Pfizer Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 58. Samsung Bioepis Corporate Summary
Table 59. Samsung Bioepis Trastuzumab Emtansine for Injection Product Offerings
Table 60. Samsung Bioepis Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 61. Mylan(Viatris) Corporate Summary
Table 62. Mylan(Viatris) Trastuzumab Emtansine for Injection Product Offerings
Table 63. Mylan(Viatris) Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 64. Celltrion Corporate Summary
Table 65. Celltrion Trastuzumab Emtansine for Injection Product Offerings
Table 66. Celltrion Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 67. Roche Corporate Summary
Table 68. Roche Trastuzumab Emtansine for Injection Product Offerings
Table 69. Roche Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 70. Accord Healthcare Corporate Summary
Table 71. Accord Healthcare Trastuzumab Emtansine for Injection Product Offerings
Table 72. Accord Healthcare Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 73. Nippon Kayaku Corporate Summary
Table 74. Nippon Kayaku Trastuzumab Emtansine for Injection Product Offerings
Table 75. Nippon Kayaku Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 76. Chugai Pharmaceutical Corporate Summary
Table 77. Chugai Pharmaceutical Trastuzumab Emtansine for Injection Product Offerings
Table 78. Chugai Pharmaceutical Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 79. Henlius Corporate Summary
Table 80. Henlius Trastuzumab Emtansine for Injection Product Offerings
Table 81. Henlius Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 82. Orifarm Corporate Summary
Table 83. Orifarm Trastuzumab Emtansine for Injection Product Offerings
Table 84. Orifarm Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 85. Trastuzumab Emtansine for Injection Production Capacity (K L) of Key Manufacturers in Global Market, 2020-2022 (K L)
Table 86. Global Trastuzumab Emtansine for Injection Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Trastuzumab Emtansine for Injection Production by Region, 2017-2022 (K L)
Table 88. Global Trastuzumab Emtansine for Injection Production by Region, 2023-2028 (K L)
Table 89. Trastuzumab Emtansine for Injection Market Opportunities & Trends in Global Market
Table 90. Trastuzumab Emtansine for Injection Market Drivers in Global Market
Table 91. Trastuzumab Emtansine for Injection Market Restraints in Global Market
Table 92. Trastuzumab Emtansine for Injection Raw Materials
Table 93. Trastuzumab Emtansine for Injection Raw Materials Suppliers in Global Market
Table 94. Typical Trastuzumab Emtansine for Injection Downstream
Table 95. Trastuzumab Emtansine for Injection Downstream Clients in Global Market
Table 96. Trastuzumab Emtansine for Injection Distributors and Sales Agents in Global Market
Table 1. Key Players of Trastuzumab Emtansine for Injection in Global Market
Table 2. Top Trastuzumab Emtansine for Injection Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Trastuzumab Emtansine for Injection Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Trastuzumab Emtansine for Injection Revenue Share by Companies, 2017-2022
Table 5. Global Trastuzumab Emtansine for Injection Sales by Companies, (K L), 2017-2022
Table 6. Global Trastuzumab Emtansine for Injection Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Trastuzumab Emtansine for Injection Price (2017-2022) & (US$/L)
Table 8. Global Manufacturers Trastuzumab Emtansine for Injection Product Type
Table 9. List of Global Tier 1 Trastuzumab Emtansine for Injection Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Trastuzumab Emtansine for Injection Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Trastuzumab Emtansine for Injection Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Trastuzumab Emtansine for Injection Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Trastuzumab Emtansine for Injection Sales (K L), 2017-2022
Table 15. By Type - Global Trastuzumab Emtansine for Injection Sales (K L), 2023-2028
Table 16. By Application – Global Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Trastuzumab Emtansine for Injection Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Trastuzumab Emtansine for Injection Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Trastuzumab Emtansine for Injection Sales (K L), 2017-2022
Table 20. By Application - Global Trastuzumab Emtansine for Injection Sales (K L), 2023-2028
Table 21. By Region – Global Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Trastuzumab Emtansine for Injection Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Trastuzumab Emtansine for Injection Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Trastuzumab Emtansine for Injection Sales (K L), 2017-2022
Table 25. By Region - Global Trastuzumab Emtansine for Injection Sales (K L), 2023-2028
Table 26. By Country - North America Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Trastuzumab Emtansine for Injection Sales, (K L), 2017-2022
Table 29. By Country - North America Trastuzumab Emtansine for Injection Sales, (K L), 2023-2028
Table 30. By Country - Europe Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Trastuzumab Emtansine for Injection Sales, (K L), 2017-2022
Table 33. By Country - Europe Trastuzumab Emtansine for Injection Sales, (K L), 2023-2028
Table 34. By Region - Asia Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Trastuzumab Emtansine for Injection Sales, (K L), 2017-2022
Table 37. By Region - Asia Trastuzumab Emtansine for Injection Sales, (K L), 2023-2028
Table 38. By Country - South America Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Trastuzumab Emtansine for Injection Sales, (K L), 2017-2022
Table 41. By Country - South America Trastuzumab Emtansine for Injection Sales, (K L), 2023-2028
Table 42. By Country - Middle East & Africa Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Trastuzumab Emtansine for Injection Sales, (K L), 2017-2022
Table 45. By Country - Middle East & Africa Trastuzumab Emtansine for Injection Sales, (K L), 2023-2028
Table 46. Genentech Corporate Summary
Table 47. Genentech Trastuzumab Emtansine for Injection Product Offerings
Table 48. Genentech Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 49. Daiichi Sankyo Corporate Summary
Table 50. Daiichi Sankyo Trastuzumab Emtansine for Injection Product Offerings
Table 51. Daiichi Sankyo Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 52. Amgen Corporate Summary
Table 53. Amgen Trastuzumab Emtansine for Injection Product Offerings
Table 54. Amgen Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 55. Pfizer Corporate Summary
Table 56. Pfizer Trastuzumab Emtansine for Injection Product Offerings
Table 57. Pfizer Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 58. Samsung Bioepis Corporate Summary
Table 59. Samsung Bioepis Trastuzumab Emtansine for Injection Product Offerings
Table 60. Samsung Bioepis Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 61. Mylan(Viatris) Corporate Summary
Table 62. Mylan(Viatris) Trastuzumab Emtansine for Injection Product Offerings
Table 63. Mylan(Viatris) Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 64. Celltrion Corporate Summary
Table 65. Celltrion Trastuzumab Emtansine for Injection Product Offerings
Table 66. Celltrion Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 67. Roche Corporate Summary
Table 68. Roche Trastuzumab Emtansine for Injection Product Offerings
Table 69. Roche Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 70. Accord Healthcare Corporate Summary
Table 71. Accord Healthcare Trastuzumab Emtansine for Injection Product Offerings
Table 72. Accord Healthcare Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 73. Nippon Kayaku Corporate Summary
Table 74. Nippon Kayaku Trastuzumab Emtansine for Injection Product Offerings
Table 75. Nippon Kayaku Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 76. Chugai Pharmaceutical Corporate Summary
Table 77. Chugai Pharmaceutical Trastuzumab Emtansine for Injection Product Offerings
Table 78. Chugai Pharmaceutical Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 79. Henlius Corporate Summary
Table 80. Henlius Trastuzumab Emtansine for Injection Product Offerings
Table 81. Henlius Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 82. Orifarm Corporate Summary
Table 83. Orifarm Trastuzumab Emtansine for Injection Product Offerings
Table 84. Orifarm Trastuzumab Emtansine for Injection Sales (K L), Revenue (US$, Mn) and Average Price (US$/L) (2017-2022)
Table 85. Trastuzumab Emtansine for Injection Production Capacity (K L) of Key Manufacturers in Global Market, 2020-2022 (K L)
Table 86. Global Trastuzumab Emtansine for Injection Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Trastuzumab Emtansine for Injection Production by Region, 2017-2022 (K L)
Table 88. Global Trastuzumab Emtansine for Injection Production by Region, 2023-2028 (K L)
Table 89. Trastuzumab Emtansine for Injection Market Opportunities & Trends in Global Market
Table 90. Trastuzumab Emtansine for Injection Market Drivers in Global Market
Table 91. Trastuzumab Emtansine for Injection Market Restraints in Global Market
Table 92. Trastuzumab Emtansine for Injection Raw Materials
Table 93. Trastuzumab Emtansine for Injection Raw Materials Suppliers in Global Market
Table 94. Typical Trastuzumab Emtansine for Injection Downstream
Table 95. Trastuzumab Emtansine for Injection Downstream Clients in Global Market
Table 96. Trastuzumab Emtansine for Injection Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Trastuzumab Emtansine for Injection Segment by Type
Figure 2. Trastuzumab Emtansine for Injection Segment by Application
Figure 3. Global Trastuzumab Emtansine for Injection Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Trastuzumab Emtansine for Injection Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Trastuzumab Emtansine for Injection Revenue, 2017-2028 (US$, Mn)
Figure 7. Trastuzumab Emtansine for Injection Sales in Global Market: 2017-2028 (K L)
Figure 8. The Top 3 and 5 Players Market Share by Trastuzumab Emtansine for Injection Revenue in 2021
Figure 9. By Type - Global Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
Figure 10. By Type - Global Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
Figure 11. By Type - Global Trastuzumab Emtansine for Injection Price (US$/L), 2017-2028
Figure 12. By Application - Global Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
Figure 13. By Application - Global Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
Figure 14. By Application - Global Trastuzumab Emtansine for Injection Price (US$/L), 2017-2028
Figure 15. By Region - Global Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
Figure 16. By Region - Global Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
Figure 17. By Country - North America Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
Figure 18. By Country - North America Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
Figure 19. US Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
Figure 24. Germany Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 25. France Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
Figure 33. China Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 37. India Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
Figure 39. By Country - South America Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
Figure 40. Brazil Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
Figure 44. Turkey Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 48. Global Trastuzumab Emtansine for Injection Production Capacity (K L), 2017-2028
Figure 49. The Percentage of Production Trastuzumab Emtansine for Injection by Region, 2021 VS 2028
Figure 50. Trastuzumab Emtansine for Injection Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Trastuzumab Emtansine for Injection Segment by Type
Figure 2. Trastuzumab Emtansine for Injection Segment by Application
Figure 3. Global Trastuzumab Emtansine for Injection Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Trastuzumab Emtansine for Injection Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Trastuzumab Emtansine for Injection Revenue, 2017-2028 (US$, Mn)
Figure 7. Trastuzumab Emtansine for Injection Sales in Global Market: 2017-2028 (K L)
Figure 8. The Top 3 and 5 Players Market Share by Trastuzumab Emtansine for Injection Revenue in 2021
Figure 9. By Type - Global Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
Figure 10. By Type - Global Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
Figure 11. By Type - Global Trastuzumab Emtansine for Injection Price (US$/L), 2017-2028
Figure 12. By Application - Global Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
Figure 13. By Application - Global Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
Figure 14. By Application - Global Trastuzumab Emtansine for Injection Price (US$/L), 2017-2028
Figure 15. By Region - Global Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
Figure 16. By Region - Global Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
Figure 17. By Country - North America Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
Figure 18. By Country - North America Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
Figure 19. US Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
Figure 24. Germany Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 25. France Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
Figure 33. China Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 37. India Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
Figure 39. By Country - South America Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
Figure 40. Brazil Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Trastuzumab Emtansine for Injection Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Trastuzumab Emtansine for Injection Sales Market Share, 2017-2028
Figure 44. Turkey Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Trastuzumab Emtansine for Injection Revenue, (US$, Mn), 2017-2028
Figure 48. Global Trastuzumab Emtansine for Injection Production Capacity (K L), 2017-2028
Figure 49. The Percentage of Production Trastuzumab Emtansine for Injection by Region, 2021 VS 2028
Figure 50. Trastuzumab Emtansine for Injection Industry Value Chain
Figure 51. Marketing Channels
